Jim Golden, formerly director of bioinformatics at New Haven, Conn.-based CuraGen, has moved on to serve as business development manager at the company’s technology spin-off, 454 Corp.
454, under wraps since its launch on June 2000, “will come out of stealth mode soon,” said Golden.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
